We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsLeafly PicksCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Leafly Picks
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Industry
  4. Florida Attorney John Morgan Considering $100M Investment in MMJ
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Industry

Florida Attorney John Morgan Considering $100M Investment in MMJ

Gage PeakeLast updated July 28, 2020
Florida attorney John Morgan holds a photo is his late father Ramon, who passed away from cancer. Morgan has said marijuana helped ease his father’s suffering as he was dying of cancer and he believes that legalization in a controlled distribution program is needed by pain sufferers in Florida, and he has provided funding to get a medicinal marijuana ballot measure that would make medical marijuana legal in Florida. This image of him was taken in his office at the Morgan and Morgan law firm in Orlando, Florida on Tuesday, September 2, 2014. (AP Photo/Alex Menendez)

One of the biggest supporters of Florida’s successful push to legalize medicinal marijuana last November, Orlando attorney John Morgan, is now considering a $100 million investment in the fledgling industry.

“What better person than me to be involved?”

He told the Miami Herald through emails that he intends to invest up to $100 million into “the right opportunities.”

Morgan, who spent nearly $3 million this past election season to help pass Amendment 2, tells the Miami Herald that he’s currently looking for “the right opportunities” to invest in the industry. All told Morgan has injected nearly $7 million combined between two medical cannabis ballot measures in the state.

Related
It’s a Close Money Race in Florida

In emails with the Herald, Morgan, who’s been mentioned as a possible gubernatorial candidate for 2018, said he’s interested in a stake in a state-licensed dispensary. So far he has yet to invest in any cannabis companies, he told the paper.

“I am prepared to invest significant monies in this industry and I plan to,” he wrote. “I have learned a great deal about the miracles of marijuana over the last five years. And what better person than me to be involved?”

Though cannabis companies have flirted with him in the past, he added, he has yet to pull the trigger.

“I have been approached by many companies here and in the U.S. and have and will continue to consider them,” Morgan wrote, forwarding the Herald a voicemail from an Arkansas businessman to underscore his point.

Morgan recently had a public falling out with a top campaign organizer over the future of Florida’s medical cannabis system. As lawmakers considered rules for the new industry, Morgan was involved in a debate over whether the state should cap the number of retail shops a licensed distributor can own and operate. Morgan was against setting such limits, while campaign chief Ben Pollara was in favor of them.

Related Stories

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
Floridainvestinglegalizationmedical marijuana
Gage Peake
Gage Peake
Gage Peake is a former staff writer for Leafly, where he specialized in data journalism, sports, and breaking news coverage. He's a graduate of the University of Nebraska-Lincoln's College of Journalism and Mass Communications.
View Gage Peake's articles

The latest in Industry

  • Nicklz dispensary was built on the nickel bag image
    Nicklz dispensary was built on the nickel bag
    Amelia Williams
  • Hemp access isn’t done yet: What you need to know about the federal government’s impending ban image
    Hemp access isn’t done yet: What you need to know about the federal government’s impending ban
    Morgan Rosendale
  • URB’N Dispensary: From pharmacist to cannabist image
    URB’N Dispensary: From pharmacist to cannabist
    Leafly Staff
  • Happy Eddie: From reality TV to real-life cannabis reform image
    Happy Eddie: From reality TV to real-life cannabis reform
    Leafly Staff
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2026 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.